| Serial Number | 98064688 |
| Word Mark | ALNUJEV |
| Filing Date | Thursday, June 29, 2023 |
| Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
| Status Date | Tuesday, September 30, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 3, 2025 |
| Goods and Services | Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use; Pharmaceutical preparations for human use for the treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, monoclonal antibodies for medical use |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, August 1, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Bristol-Myers Squibb Company |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Princeton, NJ 08543 |
| Party Name | Bristol-Myers Squibb Company |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Princeton, NJ 08543 |
| Event Date | Event Description |
| Wednesday, February 14, 2024 | NON-FINAL ACTION WRITTEN |
| Wednesday, February 14, 2024 | NON-FINAL ACTION E-MAILED |
| Wednesday, February 14, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, June 5, 2024 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Monday, July 3, 2023 | NEW APPLICATION ENTERED |
| Tuesday, August 1, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, August 2, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, February 7, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, June 5, 2024 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Monday, June 10, 2024 | TEAS PETITION TO REVIVE RECEIVED |
| Monday, June 10, 2024 | NOTICE OF REVIVAL - E-MAILED |
| Monday, June 10, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, June 10, 2024 | PETITION TO REVIVE-GRANTED |
| Tuesday, October 1, 2024 | ASSIGNED TO LIE |
| Wednesday, October 2, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, October 2, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, January 11, 2025 | FINAL REFUSAL E-MAILED |
| Friday, May 2, 2025 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, May 2, 2025 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, December 10, 2024 | ASSIGNED TO EXAMINER |
| Saturday, January 11, 2025 | FINAL REFUSAL WRITTEN |
| Saturday, January 11, 2025 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Friday, May 2, 2025 | EXAMINERS AMENDMENT E-MAILED |
| Friday, May 2, 2025 | EXAMINER'S AMENDMENT ENTERED |
| Friday, May 2, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, May 28, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, June 3, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 30, 2025 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, June 3, 2025 | PUBLISHED FOR OPPOSITION |